Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Friday, September 12, 2008
Biotech - the shape of things to come
"I think it's the natural way of things that Big Pharma is going to take over the biotech world sooner or later,"
biotechnology as a science is very innovative. biotherapeutics or biopharmaceuticals are known as 'red biotechnology. And they demonstrate clinicial benefit.
Not long ago, i heard former Merck CEO Roy Vagelos speak at Wash U, as he was plugging his new book. Recall at least two points from him:
1. The first statin drug was formed and being developed by sankyo, yet proved to be too toxic for marketing.
2. Mr. Vagelos made a very good point about biopharma, and that is that the outrageous cost does not retain value for only a few more months of life extension, complicated by concominant administration with chemo often. I concur with this last true CEO scientist.
1 comment:
biotechnology as a science is very innovative. biotherapeutics or biopharmaceuticals are known as 'red biotechnology. And they demonstrate clinicial benefit.
Not long ago, i heard former Merck CEO Roy Vagelos speak at Wash U, as he was plugging his new book. Recall at least two points from him:
1. The first statin drug was formed and being developed by sankyo, yet proved to be too toxic for marketing.
2. Mr. Vagelos made a very good point about biopharma, and that is that the outrageous cost does not retain value for only a few more months of life extension, complicated by concominant administration with chemo often. I concur with this last true CEO scientist.
Post a Comment